The Effect of Iohexol on Glucose Metabolism Compared with Metrizamide

Publisher Website
Google Scholar
Abstract
In a previous in vitro study reduced CO2 production in rat hippocampal tissue was demonstrated when metrizamide was added. This metabolic depression is believed to be a result of the 2-deoxy-D-glucose (2-DG) portion of the metrizamide molecule since 2-DG is a known competitive inhibitor of glucose metabolism. This competitive inhibition probably occurs at the cell membrane since it has never been shown that metrizamide penetrates neural cells. Further the inhibition is most likely related to competition for the membrane glucose carrier. A new nonionic contrast medium, iohexol, does not contain a 2-DG component and if the hypothesis for the metabolic inhibition is valid metabolic inhibition with iohexol should not be expected. This hypothesis was tested using the rat hippocampus model previously used for metrizamide. Iohexol was compared with metrizamide in isotonic concentrations; also the effect of hypertonicity was examined. These experiments did not demonstrate inhibition of CO2 production with iohexol at near physiologic osmolalities, however, there was a marked depressive effect with increasing osmolality. This effect from hypertonicity is, however, probably of less importance in vivo where H2O will rapidly diffuse toward the hypertonic areas. The apparent lack of interference of the iohexol molecule on glucose metabolism should therefore make iohexol a more suitable contrast medium, for subarachnoid investigations than metrizamide.

This publication has 0 references indexed in Scilit: